Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Evaluation of new immunological targets in neuromyelitis optica.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
The role of complement in neurological and neuropsychiatric diseases.
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations.
Understanding Drivers of Employment Changes in a Multiple Sclerosis Population.
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.
Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.
Remyelination by Resident Oligodendrocyte Precursor Cells in a Xenopus laevis Inducible Model of Demyelination.
Does natalizumab therapy worsen neuromyelitis optica?
An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.
Female reproductive issues in multiple sclerosis.
Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Fingolimod affects gene expression profile associated with LPS-induced memory impairment.
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants.
Seronegative neuromyelitis optica presenting with life-threatening respiratory failure.
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
Assessment of jugular endovascular malformations in chronic cerebrospinal venous insufficiency: colour-Doppler scanning and catheter venography compared with intravascular ultrasound.
The experimental autoimmune encephalomyelitis disease course is modulated by nicotine and other cigarette smoke components.
OPtimizing CNS drug development using molecular imaging.
A Potent and Selective S1P(1) Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis.
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Multiple Sclerosis Alters the Mechanical Work Performed on the Body's Center of Mass during Gait.
Multiple sclerosis: Natalizumab reduces cortical pathology in relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
238
239
240
241
242
243
244
245
246
…
next ›
last »